Martha Grogan MD, FACP, FACC

Dr. Martha Grogan is a consultant in the Department of Cardiovascular Diseases, and director of the Cardiac Amyloid Clinic, Mayo Clinic, Rochester, Minnesota.

A native of Cincinnati, Ohio, she received a BS in Biology from the University of Cincinnati. Dr. Grogan graduated from Northwestern University Medical School in 1984 and completed an internal medicine residency at Mayo Clinic in Rochester. Dr. Grogan fulfilled a three-year National Health Service Corps commitment at the Federal Medical Center, a US Bureau of Prisons tertiary care center in Rochester, after serving as Chief of Internal Medicine and Medical Director, Associate Warden. She completed her cardiovascular fellowship and subspecialty fellowship in adult congenital heart disease at Mayo Clinic in 1994.

After spending a year practicing at Kaiser Permanente in Clackamas, Oregon, she returned to Mayo Clinic Rochester as a senior associate consultant in 1995 and joined the staff in 1998. Her career focus includes echocardiography, heart failure, adult congenital heart disease, and cardiac amyloidosis. Dr. Grogan was the cardiovascular editor of mayoclinic.com, a source of health information for the general public, for more than a decade. She was the director of CV marketing, social media, and communications for several years, and was the editor of Mayo Clinic Healthy Heart for Life. She is an assistant professor of medicine, Mayo Clinic College of Medicine and Science; and has served as a faculty member of the second-year course in cardiovascular pathophysiology for nearly two decades.

In 2012, Dr. Grogan founded the cardiac amyloidosis clinic at Mayo Clinic and subsequently developed a successful cardiac amyloid clinical trial research program. Her research team has been a leader in recruitment, including having the highest US enrollment in the pivotal transthyretin amyloid cardiomyopathy (ATTR-ACT) study of tafamidis.

Other areas of her clinical research include studies analyzing diagnostic imaging, treatment, and outcomes for patients with cardiac amyloidosis. She has authored numerous scientific studies with other leading amyloid experts in addition to publishing textbook chapters covering a range of cardiac disorders, imaging techniques, and treatments.